abstract |
The present invention relates to a biomarker and target for diagnosing, evaluating prognosis and treating ankylosing spondylitis (AS). The present invention also relates to a method for producing an ankylosing spondylitis (AS) animal model, the animal model produced therefrom, and the use of this animal model to screen for agents that are pharmaceutically active in the treatment of ankylosing spondylitis (AS) method. |